Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis
Year: 2017
Type: article
Source: Annals of Hematology
Authors: Claudio Cerchione, Ilaria Peluso, Davide Nappi, Anna Emanuele Pareto, Marco Picardi, Vincenzo Martinelli, Fabrizio Pane
Institution: Federico II University Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,590
OpenAlex ID: W2588055063
